<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35697699</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19.</ArticleTitle><Pagination><StartPage>3387</StartPage><MedlinePgn>3387</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3387</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-30932-1</ELocationID><Abstract><AbstractText>COVID-19 is primarily known as a respiratory disease caused by SARS-CoV-2. However, neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke are reported in up to 30% of cases and can persist even after the infection is over (long COVID). These neurological symptoms are thought to be produced by the virus infecting the central nervous system, however we don't understand the molecular mechanisms triggering them. The neurological effects of COVID-19 share similarities to neurodegenerative diseases in which the presence of cytotoxic aggregated amyloid protein or peptides is a common feature. Following the hypothesis that some neurological symptoms of COVID-19 may also follow an amyloid etiology we identified two peptides from the SARS-CoV-2 proteome that self-assemble into amyloid assemblies. Furthermore, these amyloids were shown to be highly toxic to neuronal cells. We suggest that cytotoxic aggregates of SARS-CoV-2 proteins may trigger neurological symptoms in COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Charnley</LastName><ForeName>Mirren</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Optical Sciences and Department of Health Sciences and Biostatistics, Swinburne University of Technology, Hawthorn, VIC, 3122, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Signalling Laboratory, Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bindra</LastName><ForeName>Guneet K</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engwirda</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratcliffe</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4713-1166</Identifier><AffiliationInfo><Affiliation>La Trobe University Bioimaging Platform, Bundoora, 3086, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiangtao</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4248-2207</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences &amp; Technology, ETH Zurich, Schmelzbergstrasse 9, LFO, E23, 8092, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezzenga</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5739-2610</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences &amp; Technology, ETH Zurich, Schmelzbergstrasse 9, LFO, E23, 8092, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulett</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0003-2072-5968</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Kyunghoon</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7670-300X</Identifier><AffiliationInfo><Affiliation>Department of Physics and Materials Science, Faculty of Science, Technology and Medicine, University of Luxembourg, 162a Avenue de la Fa&#xef;encerie, Esch-sur-Alzette, L-1511, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berryman</LastName><ForeName>Joshua T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0002-6959-4607</Identifier><AffiliationInfo><Affiliation>Department of Physics and Materials Science, Faculty of Science, Technology and Medicine, University of Luxembourg, 162a Avenue de la Fa&#xef;encerie, Esch-sur-Alzette, L-1511, Luxembourg. josh.berryman@uni.lu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><Identifier Source="ORCID">0000-0003-4360-1335</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3086, Australia. nicholas.reynolds@latrobe.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>13</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35697699</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-30932-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frontera JA, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426:117486. doi: 10.1016/j.jns.2021.117486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire, A. et al. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine39, 101044 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N. Engl. J. Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med.13, eabf8396 (2021) .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brainNeuroinvasion of SARS-CoV-2 in humans and mice. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney JW, et al. Inflammation as a central mechanism in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement.: Transl. Res. Clin. Interventions. 2018;4:575&#x2013;590. doi: 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType="pmc">PMC6214864</ArticleId><ArticleId IdType="pubmed">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolppanen A-M, et al. Incidence of stroke in people with Alzheimer disease. Neurology. 2013;80:353. doi: 10.1212/WNL.0b013e31827f08c5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827f08c5</ArticleId><ArticleId IdType="pubmed">23284063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson&#x2019;s disease and its potential as therapeutic target. Transl. Neurodegeneration. 2015;4:19. doi: 10.1186/s40035-015-0042-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0042-0</ArticleId><ArticleId IdType="pmc">PMC4603346</ArticleId><ArticleId IdType="pubmed">26464797</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu, L. et al. Association of odor identification ability with amyloid-&#x3b2; and tau burden: a systematic review and meta-analysis. Front. Neurosci.14, 586330 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726324</ArticleId><ArticleId IdType="pubmed">33324151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-G, et al. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor. Cell Biosci. 2021;11:58. doi: 10.1186/s13578-021-00568-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00568-7</ArticleId><ArticleId IdType="pmc">PMC7993076</ArticleId><ArticleId IdType="pubmed">33766124</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais da Silva, M. et al. Cell death mechanisms involved in cell injury caused by SARS-CoV-2. Rev. Med. Virol.32, e2292 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646768</ArticleId><ArticleId IdType="pubmed">34590761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A, et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Saumya KU, Gadhave K, Kumar A, Giri R. Zika virus capsid anchor forms cytotoxic amyloid-like fibrils. Virology. 2021;560:8&#x2013;16. doi: 10.1016/j.virol.2021.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2021.04.010</ArticleId><ArticleId IdType="pubmed">34020329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A, et al. Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP. Biochemistry. 2015;54:2249&#x2013;2261. doi: 10.1021/acs.biochem.5b00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.5b00061</ArticleId><ArticleId IdType="pmc">PMC4903029</ArticleId><ArticleId IdType="pubmed">25785896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangan R, et al. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look. RNA. 2020;26:937&#x2013;959. doi: 10.1261/rna.076141.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.076141.120</ArticleId><ArticleId IdType="pmc">PMC7373990</ArticleId><ArticleId IdType="pubmed">32398273</ArticleId></ArticleIdList></Reference><Reference><Citation>Galkin AP. Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease. Prion. 2021;15:53&#x2013;55. doi: 10.1080/19336896.2021.1910468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2021.1910468</ArticleId><ArticleId IdType="pmc">PMC8078534</ArticleId><ArticleId IdType="pubmed">33876719</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam N, et al. Microbial functional amyloids serve diverse purposes for structure, adhesion and defence. Biophysical Rev. 2019;11:287&#x2013;302. doi: 10.1007/s12551-019-00526-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12551-019-00526-1</ArticleId><ArticleId IdType="pmc">PMC6557962</ArticleId><ArticleId IdType="pubmed">31049855</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NS, et al. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer&#x2019;s disease. J. Neuroinflammation. 2005;2:9. doi: 10.1186/1742-2094-2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-2-9</ArticleId><ArticleId IdType="pmc">PMC555557</ArticleId><ArticleId IdType="pubmed">15762998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayeb-Fligelman, E. et al. Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2. Preprint at bioRxiv 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, et al. Liquid&#x2013;liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. Cell Res. 2020;30:1143&#x2013;1145. doi: 10.1038/s41422-020-00408-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00408-2</ArticleId><ArticleId IdType="pmc">PMC7477871</ArticleId><ArticleId IdType="pubmed">32901111</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A, Ib&#xe1;&#xf1;ez de Opakua A, Rankovic M, Zweckstetter M. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. Nat. Commun. 2020;11:6041. doi: 10.1038/s41467-020-19843-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19843-1</ArticleId><ArticleId IdType="pmc">PMC7699647</ArticleId><ArticleId IdType="pubmed">33247108</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham CL, et al. Viral M45 and necroptosis-associated proteins form heteromeric amyloid assemblies. EMBO Rep. 2019;20:e46518. doi: 10.15252/embr.201846518.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201846518</ArticleId><ArticleId IdType="pmc">PMC6362354</ArticleId><ArticleId IdType="pubmed">30498077</ArticleId></ArticleIdList></Reference><Reference><Citation>Pancer K, et al. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans. PLOS Pathog. 2020;16:e1008959. doi: 10.1371/journal.ppat.1008959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008959</ArticleId><ArticleId IdType="pmc">PMC7755277</ArticleId><ArticleId IdType="pubmed">33301543</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, J. et al. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses 12, 244 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7077191</ArticleId><ArticleId IdType="pubmed">32098422</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543&#x2013;550. doi: 10.1111/j.1440-1843.2010.01720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara C, et al. ILQINS hexapeptide, identified in lysozyme left-handed helical ribbons and nanotubes, forms right-handed helical ribbons and crystals. J. Am. Chem. Soc. 2014;136:4732&#x2013;4739. doi: 10.1021/ja500445z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja500445z</ArticleId><ArticleId IdType="pubmed">24580564</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds NP, et al. Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides. Nat. Commun. 2017;8:1338. doi: 10.1038/s41467-017-01424-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01424-4</ArticleId><ArticleId IdType="pmc">PMC5673901</ArticleId><ArticleId IdType="pubmed">29109399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanjani AAH, et al. Kinetic control of parallel versus antiparallel amyloid aggregation via shape of the growing aggregate. Sci. Rep. 2019;9:15987. doi: 10.1038/s41598-019-52238-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52238-x</ArticleId><ArticleId IdType="pmc">PMC6831816</ArticleId><ArticleId IdType="pubmed">31690748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaguri D, et al. Nanomechanical properties and phase behavior of phenylalanine amyloid ribbon assemblies and amorphous self-healing hydrogels. ACS Appl. Mater. Interfaces. 2020;12:21992&#x2013;22001. doi: 10.1021/acsami.0c01574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.0c01574</ArticleId><ArticleId IdType="pubmed">32307977</ArticleId></ArticleIdList></Reference><Reference><Citation>Usov I, Mezzenga R. FiberApp: an open-source software for tracking and analyzing polymers, filaments, biomacromolecules, and fibrous objects. Macromolecules. 2015;48:1269&#x2013;1280. doi: 10.1021/ma502264c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ma502264c</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha SK, Sirota EB, Garoff S, Stanley HB. X-ray and neutron scattering from rough surfaces. Phys. Rev. B. 1988;38:2297&#x2013;2311. doi: 10.1103/PhysRevB.38.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevB.38.2297</ArticleId><ArticleId IdType="pubmed">9946532</ArticleId></ArticleIdList></Reference><Reference><Citation>Micsonai A, et al. BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra. Nucleic Acids Res. 2018;46:W315&#x2013;W322. doi: 10.1093/nar/gky497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky497</ArticleId><ArticleId IdType="pmc">PMC6031044</ArticleId><ArticleId IdType="pubmed">29893907</ArticleId></ArticleIdList></Reference><Reference><Citation>Micsonai A, et al. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc. Natl Acad. Sci. USA. 2015;112:E3095&#x2013;E3103.. doi: 10.1073/pnas.1500851112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1500851112</ArticleId><ArticleId IdType="pmc">PMC4475991</ArticleId><ArticleId IdType="pubmed">26038575</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler-Abramovich L, et al. Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. Nat. Chem. Biol. 2012;8:701&#x2013;706. doi: 10.1038/nchembio.1002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1002</ArticleId><ArticleId IdType="pubmed">22706200</ArticleId></ArticleIdList></Reference><Reference><Citation>Do TD, Kincannon WM, Bowers MT. Phenylalanine oligomers and fibrils: the mechanism of assembly and the importance of tetramers and counterions. J. Am. Chem. Soc. 2015;137:10080&#x2013;10083. doi: 10.1021/jacs.5b05482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.5b05482</ArticleId><ArticleId IdType="pubmed">26244895</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadana D, Reynolds NP, Conn CE, Val&#xe9;ry C. Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design. Interface Focus. 2017;7:20160160. doi: 10.1098/rsfs.2016.0160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsfs.2016.0160</ArticleId><ArticleId IdType="pmc">PMC5474041</ArticleId><ArticleId IdType="pubmed">28630679</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomont JP, et al. Not all &#x3b2;-sheets are the same: amyloid infrared spectra, transition dipole strengths, and couplings investigated by 2D IR spectroscopy. J. Phys. Chem. B. 2017;121:8935&#x2013;8945. doi: 10.1021/acs.jpcb.7b06826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.7b06826</ArticleId><ArticleId IdType="pmc">PMC5705941</ArticleId><ArticleId IdType="pubmed">28851219</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadana D, Reynolds NP, Conn CE, Val&#xe9;ry C. pH-dependent self-assembly of human neuropeptide hormone GnRH into functional amyloid nanofibrils and hexagonal phases. ACS Appl. Bio Mater. 2019;2:3601&#x2013;3606. doi: 10.1021/acsabm.9b00468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.9b00468</ArticleId><ArticleId IdType="pubmed">35030746</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanjani AAH, et al. Amyloid evolution: antiparallel replaced by parallel. Biophysical J. 2020;118:2526&#x2013;2536. doi: 10.1016/j.bpj.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7231890</ArticleId><ArticleId IdType="pubmed">32311316</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadana D, et al. Heparin assisted assembly of somatostatin amyloid nanofibrils results in disordered precipitates by hindrance of protofilaments interactions. Nanoscale. 2018;10:18195&#x2013;18204. doi: 10.1039/C8NR02159G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8NR02159G</ArticleId><ArticleId IdType="pubmed">30141801</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadana D, et al. Human neuropeptide substance P self-assembles into semi-flexible nanotubes that can be manipulated for nanotechnology. Nanoscale. 2020;12:22680&#x2013;22687. doi: 10.1039/D0NR05622G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0NR05622G</ArticleId><ArticleId IdType="pubmed">33165459</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer&#x2019;s disease. Acta Neuropathologica Commun. 2014;2:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4207354</ArticleId><ArticleId IdType="pubmed">25231068</ArticleId></ArticleIdList></Reference><Reference><Citation>Xicoy H, Wieringa B, Martens GJM. The SH-SY5Y cell line in Parkinson&#x2019;s disease research: a systematic review. Mol. Neurodegeneration. 2017;12:10. doi: 10.1186/s13024-017-0149-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0149-0</ArticleId><ArticleId IdType="pmc">PMC5259880</ArticleId><ArticleId IdType="pubmed">28118852</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishtal J, et al. Toxicity of amyloid-&#x3b2; peptides varies depending on differentiation route of SH-SY5Y cells. J. Alzheimers Dis. 2019;71:879&#x2013;887. doi: 10.3233/JAD-190705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190705</ArticleId><ArticleId IdType="pubmed">31450506</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029&#x2013;2044. doi: 10.1038/s41418-021-00814-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00814-y</ArticleId><ArticleId IdType="pmc">PMC8257776</ArticleId><ArticleId IdType="pubmed">34099897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecky-Bromberg SA, et al. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007;81:548&#x2013;557. doi: 10.1128/JVI.01782-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01782-06</ArticleId><ArticleId IdType="pmc">PMC1797484</ArticleId><ArticleId IdType="pubmed">17108024</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall KE, Marchante R, Xue W-F, Serpell LC. The relationship between amyloid structure and cytotoxicity. Prion. 2014;8:192&#x2013;196. doi: 10.4161/pri.28860.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.28860</ArticleId><ArticleId IdType="pmc">PMC4189889</ArticleId><ArticleId IdType="pubmed">24819071</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue W-F, et al. Fibril fragmentation enhances amyloid cytotoxicity. J. Biol. Chem. 2009;284:34272&#x2013;34282. doi: 10.1074/jbc.M109.049809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.049809</ArticleId><ArticleId IdType="pmc">PMC2797196</ArticleId><ArticleId IdType="pubmed">19808677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocanu M-M, et al. Polymorphism of hen egg white lysozyme amyloid fibrils influences the cytotoxicity in LLC-PK1 epithelial kidney cells. Int. J. Biol. Macromolecules. 2014;65:176&#x2013;187. doi: 10.1016/j.ijbiomac.2014.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2014.01.030</ArticleId><ArticleId IdType="pubmed">24444882</ArticleId></ArticleIdList></Reference><Reference><Citation>Novitskaya V, Bocharova OV, Bronstein I, Baskakov IV. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J. Biol. Chem. 2006;281:13828&#x2013;13836. doi: 10.1074/jbc.M511174200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M511174200</ArticleId><ArticleId IdType="pubmed">16554307</ArticleId></ArticleIdList></Reference><Reference><Citation>El Moustaine D, et al. Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure. J. Biol. Chem. 2011;286:13448&#x2013;13459. doi: 10.1074/jbc.M110.192872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.192872</ArticleId><ArticleId IdType="pmc">PMC3075691</ArticleId><ArticleId IdType="pubmed">21357423</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamcik J, Mezzenga R. Amyloid polymorphism in the protein folding and aggregation energy landscape. Angew. Chem. Int. Ed. 2018;57:8370&#x2013;8382. doi: 10.1002/anie.201713416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201713416</ArticleId><ArticleId IdType="pubmed">29446868</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Escamilla A-M, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004;22:1302&#x2013;1306. doi: 10.1038/nbt1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1012</ArticleId><ArticleId IdType="pubmed">15361882</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson MJ, et al. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl Acad. Sci. USA. 2006;103:4074&#x2013;4078. doi: 10.1073/pnas.0511295103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0511295103</ArticleId><ArticleId IdType="pmc">PMC1449648</ArticleId><ArticleId IdType="pubmed">16537487</ArticleId></ArticleIdList></Reference><Reference><Citation>Macke, T. J. &amp; Case, D. A. Modeling unusual nucleic acid structures. In Molecular Modeling of Nucleic Acids (eds Leontis, N. B. &amp; SantaLucia, J.) Vol. 682, 379&#x2013;393 (American Chemical Society, 1997).</Citation></Reference><Reference><Citation>Jorgensen WL, et al. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983;79:926&#x2013;935. doi: 10.1063/1.445869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.445869</ArticleId></ArticleIdList></Reference><Reference><Citation>Debiec KT, et al. Further along the road less traveled: AMBER ff15ipq, an original protein force field built on a self-consistent physical model. J. Chem. Theory Comput. 2016;12:3926&#x2013;3947. doi: 10.1021/acs.jctc.6b00567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.6b00567</ArticleId><ArticleId IdType="pmc">PMC4980686</ArticleId><ArticleId IdType="pubmed">27399642</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon-Ferrer R, et al. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J. Chem. Theory Comput. 2013;9:3878&#x2013;3888. doi: 10.1021/ct400314y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct400314y</ArticleId><ArticleId IdType="pubmed">26592383</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke D, et al. ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions. J. Appl. Crystallogr. 2017;50:1212&#x2013;1225. doi: 10.1107/S1600576717007786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S1600576717007786</ArticleId><ArticleId IdType="pmc">PMC5541357</ArticleId><ArticleId IdType="pubmed">28808438</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon IKH, et al. Phosphoinositide-mediated oligomerization of a defensin induces cell lysis. eLife. 2014;3:e01808. doi: 10.7554/eLife.01808.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.01808</ArticleId><ArticleId IdType="pmc">PMC3968744</ArticleId><ArticleId IdType="pubmed">24692446</ArticleId></ArticleIdList></Reference><Reference><Citation>Varrette, S., Bouvry, P., Cartiaux, H. &amp; Georgatos, F. Management of an academic HPC cluster: the UL experience. In 2014 International Conference on High Performance Computing &amp; Simulation (HPCS), 21&#x2013;25 July 2014, 959&#x2013;967 (2014).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>